<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Medicine/Medical-Specialties/Psychiatry/Journals.xml">
<title>Journals RSS : Gourt</title>
<link>http://www.gourt.com/Health/Medicine/Medical-Specialties/Psychiatry/Journals.xml</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-11-07T14:08+37:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Journals RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/401?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/402?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/404?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/411?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/419?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/428?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/434?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/442?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/444?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/451?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/459?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/462?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/470?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/479?rss=1" />
  <rdf:li rdf:resource="http://apt.rcpsych.org/cgi/content/short/15/6/479-a?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/A28?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1201?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1205?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1207?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1209?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1211?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1215?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1217?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1222?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1229?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1238?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1244?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1251?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1258?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1269?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1278?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1286?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1295?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1295-a?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1296?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1296-a?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1297?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1298?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1298-a?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1299?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1300?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1301?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1301-a?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1302?rss=1" />
  <rdf:li rdf:resource="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1304?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1154?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1158?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1159?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1162?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1173?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1178?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1189?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1201?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1214?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1221?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1233?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1244?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1253?rss=1" />
  <rdf:li rdf:resource="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1263?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/353?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/357?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/358?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/364?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/370?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/376?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/377?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/383?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/389?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/393?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/394?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/399?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/400?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/403?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/404?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/407?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/410?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/413?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/417?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/418?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/422?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/423?rss=1" />
  <rdf:li rdf:resource="http://ap.psychiatryonline.org/cgi/content/short/33/5/427?rss=1" />
  <rdf:li rdf:resource="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&#x26;db=PubMed&#x26;cmd=Retrieve&#x26;list_uids=19819115&#x26;dopt=Abstract" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/401?rss=1">
<title>Mindreadings [From the Editor]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/401?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/402?rss=1">
<title>Letter from America: acute in-patient psychiatry bed shortages [Editorials]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/402?rss=1</link>
<description><![CDATA[
The number of in-patient beds for psychiatric treatment in America has declined dramatically over the past 40 years. Public and private policies have encouraged an extremely short-term, crisis-stabilisation model of treatment. This is true on both general and subspecialty units. As a result, readmissions have increased, emergency rooms are crowded, and many patients end up homeless or incarcerated in the criminal justice system. These changes have created a public health crisis in America, and are the greatest challenges that American psychiatry faces today.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/404?rss=1">
<title>The role of the medical director in mental health [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/404?rss=1</link>
<description><![CDATA[
This article sets out the history of medical directorship, outlines the authors&rsquo; view of the current contribution that medical directors can and should be making to the mental health arena and looks forward to the possibilities of this evolving role. The focus of the article is mainly on English policy and healthcare structures, recognising that these vary in the other jurisdictions of the UK. However, certain principles should be of wider interest and application.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/411?rss=1">
<title>Puerperal psychosis: identifying and caring for women at risk [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/411?rss=1</link>
<description><![CDATA[
Puerperal (postpartum) psychosis &ndash; the acute onset of a manic or psychotic episode shortly after childbirth &ndash; most commonly occurs in women with a bipolar disorder diathesis who have a vulnerability to a specific childbirth-related trigger. Women with bipolar disorder are at particularly high risk of puerperal psychosis, with a severe affective episode following between 25 and 50% of deliveries. Suicide is a leading cause of maternal death in the UK and it is clear that we must do more to identify and better manage women at high risk of illness related to childbirth. The clinical picture of puerperal psychosis can vary dramatically from hour to hour and can escalate quickly to a true psychiatric emergency. It is vital that clinical services identify women who are unwell and can respond quickly to the severity of illness, delivering treatment in the most appropriate setting for the mother and her baby.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/419?rss=1">
<title>Clinical significance of neurological abnormalities in psychosis [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/419?rss=1</link>
<description><![CDATA[
The neurological deficits in sensory and motor function in schizophrenia have been described using a confusing variety of terms, reflecting their uncertain relevance and significance to psychosis. In this article we explore the nature of neurological abnormalities in psychosis, describe their assessment and suggest their potential relevance for clinician and patient. We propose that the assessment of neurological abnormalities and extrapyramidal side-effects should figure in the assessment of any patient with psychosis, particularly at illness onset. Furthermore, we suggest that neurological abnormalities can inform prognostic predictions and help to identify patients with more complex future care needs.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/428?rss=1">
<title>Understanding community care law in England and Wales [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/428?rss=1</link>
<description><![CDATA[
Although psychiatrists in England and Wales are generally familiar with the Mental Health Act 1983 and the Mental Capacity Act 2005, there is a body of law that is available to assist patients in the community with which they are generally less familiar. There are two main reasons for this. The first is that it is a rather confused amalgam of different statutes and case law affecting each other in ways that are less than clear. The other is that the care programme approach (CPA) was meant to cut through all this and make care provision straightforward. In fact, the latter has never been the case and community care law has always sat uneasily alongside the CPA, but in October 2008 the CPA was withdrawn from some patients with mental health problems. This article explains what is meant by community care law and how psychiatrists can use it to help their patients.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/434?rss=1">
<title>Self-harm in adolescents [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/434?rss=1</link>
<description><![CDATA[
Self-harm in adolescents is common and is increasing. It can present to professionals as a symptom of major mental health disturbance or it can form part of a cultural &lsquo;norm&rsquo;. This article reviews current knowledge about self-harm in 12- to 18-year-olds. Definitions of self-harming behaviour, epidemiological and aetiological factors, risk assessment and management of self-harming in various settings are discussed in terms of pragmatic clinical approaches and evidence-based practice.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/442?rss=1">
<title>The challenges of managing self-harm effectively: INVITED COMMENTARY ON... SELF-HARM IN ADOLE SCENTS [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/442?rss=1</link>
<description><![CDATA[
This commentary discusses how much we appear to know about self-harm and the circumstances in which it may occur but how little we really know about what works in managing it. It reviews how suggestions for its management conflict with what we know about self-harm and the outcomes of young people. The challenge appears to be how better to identify those at risk of further self-harm and to train frontline staff in this, so that at-risk individuals may be referred to specialist services. Perhaps there is also a need to review the evidence for what actually works in reducing repetition of self-harm.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/444?rss=1">
<title>Article 2 of the Human Rights Act 1998 and the treatment of prisoners [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/444?rss=1</link>
<description><![CDATA[
People detained in prisons, psychiatric hospitals, police custody and immigration detention centres remain a cause of concern, particularly to professionals, politicians and the media. As the number of people detained by the state increases, Courts have been taking an increasing interest in cases in which individuals have died in state custody. Such cases are subsumed under Article 2 of the Human Rights Act 1998 &ndash; the right to life. Article 2 case law has elucidated key principles that can be applied in practice. Importantly, it imposes on states not only a negative duty not to take life intentionally or negligently, but also a positive duty to safeguard life. The inherent positive obligations have two aspects: first, there is a duty to provide an effective and impartial investigation in cases of death resulting from the activities of state officials, and second, a duty to safeguard and protect life.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/451?rss=1">
<title>Clinical implications of neuropsychiatric systemic lupus erythematosus [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/451?rss=1</link>
<description><![CDATA[
Systemic lupus erythematosus (SLE) is a disorder which can affect the central nervous system and result in a broad range of psychiatric syndromes such as psychosis, mood disorders, acute confusion and cognitive dysfunction. Despite the robust nomenclature of neuropsychiatric SLE (NPSLE), psychiatric syndromes in patients are often non-specific and may be secondary to concurrent non-SLE-related conditions and complications of medical therapies. Although the exact immunopathological mechanism for psychiatric presentation remains elusive, prompt exclusion of other factors contributing to the psychiatric symptoms coupled with effective assessment strategies and management with immunosuppression and psychiatric therapy are imperative. Psychiatrists and rheumatologists must work in close liaison to identify, treat and prognosticate patients with psychiatric syndromes in order to improve their quality of life, vocational aptitude and, ultimately, survival.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/459?rss=1">
<title>Metamorphosis by Franz Kafka [Mindreadings]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/459?rss=1</link>
<description><![CDATA[
This article examines the short story Metamorphosis by the enigmatic Czech writer Franz Kafka, whose work has been the subject of extensive critical discussion. His writings have been seen in the context of existentialism, Jewish mysticism and as a warning of the advent of totalitarianism. Kafka has attracted the attention of psychoanalysts and psychiatrists, who have maintained that his life and work manifest evidence of unresolved Oedipal issues and of schizoid personality. Metamorphosis is open to a multitude of interpretations, but a potentially fruitful approach is to see parallels between the predicament of the story&rsquo;s main character, Gregor Samsa, and that of people with severe mental illness. The story highlights the fate of those who are judged to be different by society and how issues of alienation, impaired communication and rejection arise.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/462?rss=1">
<title>Interpersonal dynamics and multidisciplinary teamwork [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/462?rss=1</link>
<description><![CDATA[
Analysing interpersonal dynamics is an approach through which the multidisciplinary team can develop a shared understanding of their patients. This empirically based method provides an insight into repeated patterns of dysfunctional behaviour, which not only have been evident in the past, but are currently having an impact on the patient&rsquo;s relationships with caring staff. The technique is accessible to any team member with only minimal training required. It provides the team with a coherent map of the patient&rsquo;s relationship patterns that underpins the formulation of an effective strategy for care. The multidisciplinary team is then able to work towards shared goals, supporting all members in their provision of effective interventions within the full range of therapeutic modalities. The approach promotes positive staff&ndash;patient interactions and provides an additional dimension to the assessment and management of risk.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/470?rss=1">
<title>Systemic thinking and values-based practice [Articles]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/470?rss=1</link>
<description><![CDATA[
Values-based practice is a new approach to working with complex and conflicting values in mental health practice. Theoretically, it argues that many clinical and ethical dilemmas in psychiatry arise because of the different value perspectives taken by the players involved. By exploring the differences in value systems &lsquo;held&rsquo; by each player, it may be possible to come to a richer consensus that can incorporate both similarities and differences. In particular, values-based practice suggests that, traditionally, the value perspective of the patient is often either not considered or is ignored, and that by giving it voice, clinical practice will become more patient-centred. In this article, I will compare values-based practice with other types of systemic thinking in mental healthcare and I will discuss some areas of clinical practice where values-based practice may be difficult to apply.
]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/479?rss=1">
<title>&#x27;At last I am alone&#x27;, from the diary of Dora Carrington [In Other Words]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/479?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://apt.rcpsych.org/cgi/content/short/15/6/479-a?rss=1">
<title>Correction [Correction]</title>
<link>http://apt.rcpsych.org/cgi/content/short/15/6/479-a?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/A28?rss=1">
<title>In This Issue [In This Issue]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/A28?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1201?rss=1">
<title>Postpartum Mood Disorders: Genetic Progress and Treatment Paradigms [Editorials]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1201?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1205?rss=1">
<title>Closing the Gap Between Guidelines for Bipolar Disorder Treatment and Clinical Practice [Editorials]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1205?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1207?rss=1">
<title>Identifying Neighborhood Stressors in Assessment of Drug Treatment Continuity and Relapse [Editorials]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1207?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1209?rss=1">
<title>Expanding Treatment Options for Cocaine Dependence [Editorials]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1209?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1211?rss=1">
<title>New Models of Collaboration Between Criminal Justice and Mental Health Systems [Commentary]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1211?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1215?rss=1">
<title>Conclusion: Mental Health in the Mainstream of Public Policy [Commentary]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1215?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1217?rss=1">
<title>Bipolar II Postpartum Depression: Detection, Diagnosis, and Treatment [Treatment in Psychiatry]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1217?rss=1</link>
<description><![CDATA[
Research on postpartum mood disorders has focused primarily on major depressive disorder, bipolar I disorder, and puerperal psychosis and has largely ignored or neglected bipolar II disorder. Hypomanic symptoms are common after delivery but frequently unrecognized. DSM-IV does not consider early postpartum hypomania as a significant diagnostic feature. Although postpartum hypomania may not cause marked impairment in social or occupational functioning, it is often associated with subsequent, often disabling depression. Preliminary evidence suggests that bipolar II depression arising in the postpartum period is often misdiagnosed as unipolar major depressive disorder. The consequences of the misdiagnosis can be particularly serious because of delayed initiation of appropriate treatment and the inappropriate prescription of antidepressants. Moreover, no pharmacological or psychotherapeutic studies of bipolar postpartum depression are available to guide clinical decision making. Also lacking are screening instruments designed specifically for use before or after delivery in women with suspected bipolar depression. It is recommended that the treatment of postpartum bipolar depression follow the same guidelines as the treatment of nonpuerperal bipolar II depression, using medications that are compatible with lactation. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1222?rss=1">
<title>Clinical Trials Design Lessons From the CATIE Study [Reviews and Overviews]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1222?rss=1</link>
<description><![CDATA[
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study was funded by the National Institute of Mental Health to compare the effectiveness of drugs for schizophrenia. The focus here is not on its conclusions but on the knotty issues of design and methods, in order to support appropriate clinical interpretation of the conclusions, and on using the CATIE experience to indicate directions for improvement of future clinical trials. While many of the CATIE design and implementation decisions are excellent and serve as models for future research, other decisions resulted in a study with a large study group but inadequate power. Multiple treatment interventions, unbalanced randomization within and across clinical sites, and multiple secondary outcomes are among the issues that require even more serious consideration in future large multisite clinical trials. Moreover, it is crucial to clarify whether the intent of a study is to establish superiority of some treatments or to establish equivalence, for the appropriate designs and analyses differ in these situations. If the study is designed, as was CATIE, to demonstrate some treatments&rsquo; superiority, statistically nonsignificant results should not be misinterpreted as evidence of "equivalence." For establishing either superiority or equivalence, future treatment comparisons might better be designed with fewer sites, more subjects per site, fewer treatments, and fewer outcomes, in order to have the power for definitively establishing superiority or equivalence at a lower cost. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1229?rss=1">
<title>Genome-Wide Linkage and Follow-Up Association Study of Postpartum Mood Symptoms [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1229?rss=1</link>
<description><![CDATA[
OBJECTIVE: Family studies have suggested that postpartum mood symptoms might have a partly genetic etiology. The authors used a genome-wide linkage analysis to search for chromosomal regions that harbor genetic variants conferring susceptibility for such symptoms. The authors then fine-mapped their best linkage regions, assessing single nucleotide polymorphisms (SNPs) for genetic association with postpartum symptoms. METHOD: Subjects were ascertained from two studies: the NIMH Genetics Initiative Bipolar Disorder project and the Genetics of Recurrent Early-Onset Depression. Subjects included women with a history of pregnancy, any mood disorder, and information about postpartum symptoms. In the linkage study, 1,210 women met criteria (23% with postpartum symptoms), and 417 microsatellite markers were analyzed in multipoint allele sharing analyses. For the association study, 759 women met criteria (25% with postpartum symptoms), and 16,916 SNPs in the regions of the best linkage peaks were assessed for association with postpartum symptoms. RESULTS: The maximum linkage peak for postpartum symptoms occurred on chromosome 1q21.3-q32.1, with a chromosome-wide significant likelihood ratio Z score (ZLR) of 2.93 (permutation p=0.02). This was a significant increase over the baseline ZLR of 0.32 observed at this locus among all women with a mood disorder (permutation p=0.004). Suggestive linkage was also found on 9p24.3-p22.3 (ZLR=2.91). In the fine-mapping study, the strongest implicated gene was HMCN1 (nominal p=0.00017), containing four estrogen receptor binding sites, although this was not region-wide significant. CONCLUSIONS: This is the first study to examine the genetic etiology of postpartum mood symptoms using genome-wide data. The results suggest that genetic variations on chromosomes 1q21.3-q32.1 and 9p24.3-p22.3 may increase susceptibility to postpartum mood symptoms.  
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1238?rss=1">
<title>Anxiety and Outcome in Bipolar Disorder [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1238?rss=1</link>
<description><![CDATA[
OBJECTIVE: Important differences exist between bipolar disorder with and without comorbid anxiety, but little is known about the long-term prognostic significance of coexisting anxiety in bipolar disorder. The authors sought to identify the anxiety features most predictive of subsequent affective morbidity and to evaluate the persistence of the prognostic relationship. METHOD: Probands with bipolar I or II disorder from the National Institute of Mental Health Collaborative Depression Study were followed prospectively for a mean of 17.4 years (SD=8.4) and were characterized according to various manifestations of anxiety present at baseline. A series of general linear model analyses examined the relationship between these measures and the proportion of follow-up weeks in episodes of major depression and in episodes of mania or hypomania. RESULTS: Patients whose episode at intake included a depressive phase spent nearly three times as many weeks in depressive episodes than did those whose intake episode was purely manic. Psychic and somatic anxiety ratings, but not the presence of panic attacks or of any lifetime anxiety disorder, added to the predictive model. Combined ratings of psychic and somatic anxiety were associated in a stepwise fashion with a greater proportion of weeks in depressive episodes, and this relationship persisted over the follow-up period. CONCLUSIONS: The presence of higher levels of anxiety during bipolar mood episodes appears to mark an illness of substantially greater long-term depressive morbidity. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1244?rss=1">
<title>Enhancing Multiyear Guideline Concordance for Bipolar Disorder Through Collaborative Care [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1244?rss=1</link>
<description><![CDATA[
OBJECTIVE: Implementation of evidence-based care for serious mental illnesses such as bipolar disorder has been suboptimal. Improving and sustaining concordance with clinical practice guidelines has been a cornerstone of efforts to enhance evidence-based care and improve outcomes. For bipolar disorder, however, there has been only one regional controlled trial reporting guideline concordance, and no data are available for time periods longer than 1 year. In a multiregion effectiveness trial in veterans with bipolar disorder, the authors assessed the effects of a collaborative care model for this disorder on guideline concordance in care over a 3-year period. METHOD: A total of 306 participants with bipolar disorder were randomly assigned at hospital discharge to 3 years of follow-up treatment with a collaborative care model or to usual care. The collaborative care model included provider support through simplified practice guidelines, patient skills management enhancement through group psychoeducation, and facilitated access and continuity via nurse care management. Concordance with guideline-recommended antimanic pharmacotherapy was assessed at baseline and prospectively over six 6-month epochs. Group differences were assessed with generalized estimating equations that controlled for relevant covariates. RESULTS: The collaborative care model achieved significantly higher rates of guideline-concordant antimanic treatment than usual care over the entire follow-up period. Baseline guideline concordance, but not patient age or bipolar type, was associated with higher concordance. CONCLUSIONS: Multicomponent collaborative care models, which include not only provider support for guideline implementation but also patient self-management skill enhancement and facilitated treatment access and continuity, can improve guideline concordance over the long term, even in severely impaired patients. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1251?rss=1">
<title>Association of Pre-Onset Cannabis, Alcohol, and Tobacco Use With Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1251?rss=1</link>
<description><![CDATA[
OBJECTIVE: Several reports suggest that cannabis use is associated with an earlier age at onset of psychosis, although not all studies have operationalized cannabis use as occurring prior to onset of symptoms. This study addressed whether pre-onset cannabis use, alcohol use, and tobacco use are associated with an earlier age at onset of prodromal and psychotic symptoms. Effects of the progression of frequency of use were examined through time-dependent covariates in survival analyses. METHOD: First-episode patients (N=109) hospitalized in three public-sector inpatient psychiatric units underwent in-depth cross-sectional retrospective assessments. Prior substance use and ages at onset of prodromal and psychotic symptoms were determined by standardized methods, and analyses were conducted using Cox regression modeling. RESULTS: Whereas classifying participants according to maximum frequency of use prior to onset (none, ever, weekly, or daily) revealed no significant effects of cannabis or tobacco use on risk of onset, analysis of change in frequency of use prior to onset indicated that progression to daily cannabis and tobacco use was associated with an increased risk of onset of psychotic symptoms. Similar or even stronger effects were observed when onset of illness or prodromal symptoms was the outcome. A gender-by-daily-cannabis-use interaction was observed; progression to daily use resulted in a much larger increased relative risk of onset of psychosis in females than in males. CONCLUSIONS: Pre-onset cannabis use may hasten the onset of psychotic as well as prodromal symptoms. Age at onset is a key prognostic factor in schizophrenia, and discovering modifiable predictors of age at onset is crucial. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1258?rss=1">
<title>The Influence of Neighborhood Environment on Treatment Continuity and Rehospitalization in Dually Diagnosed Patients Discharged From Acute Inpatient Care [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1258?rss=1</link>
<description><![CDATA[
OBJECTIVE: Environmental contingencies inherent in neighborhoods and communities have been shown to affect individual behavior. The authors analyzed neighborhood and individual factors predicting initial outpatient treatment attendance and rehospitalization within 1 year among patients who were dually diagnosed with at least one mental disorder and a substance use disorder and discharged from an acute psychiatric inpatient care unit. METHOD: Stepwise-forward logistic regression modeling and a geographic information system were utilized to assess data extracted from the medical records of 380 patients who, upon hospital admission, had one or more mental health disorders and a positive urine drug screen for prototypical illicit drugs. Geographic data on patients&rsquo; neighborhood environment were obtained from public sources. Outcome variables were whether a patient attended the first outpatient treatment appointment within 30 days of hospital discharge and whether a patient was readmitted to the inpatient unit within 1 year of discharge. Predictor variables were features relating to individual-level patient characteristics and features associated with neighborhood environment. RESULTS: Factors that decreased the likelihood of attending the initial outpatient treatment were returning home following hospitalization (versus returning to an institutional setting), residing in an area with a high vacant housing rate, residing in an area far from an Alcoholics Anonymous meeting location, having the chief complaint of bizarre behavior (i.e., grossly inappropriate behavior), and having a urine drug screen positive for heroin. The likelihood of being rehospitalized within 1 year was greater for Hispanic patients, patients who had at least one prior hospital admission, and patients who lived in close proximity to a Narcotics Anonymous meeting location. Patients living in areas with higher educational attainment had a reduced likelihood of rehospitalization. CONCLUSIONS: A more explicit focus on the neighborhood and community context represents an important area in psychiatry, in terms of both research and clinical practice, which can potentially enhance long-term care and treatment planning for psychiatric patients. Future research is needed to better understand the influence of the neighborhood environment to help predict important clinical outcomes. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1269?rss=1">
<title>Randomized, Double-Blind, Placebo-Controlled Trial of Vigabatrin for the Treatment of Cocaine Dependence in Mexican Parolees [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1269?rss=1</link>
<description><![CDATA[
OBJECTIVE: Cocaine dependence is associated with severe medical, psychiatric, and social morbidity, but no pharmacotherapy is approved for its treatment in the United States. The atypical antiepileptic vigabatrin (-vinyl gamma-aminobutyric acid [GABA]) has shown promise in animal studies and open-label trials. The purpose of the present study was to assess the efficacy of vigabatrin for short-term cocaine abstinence in cocaine-dependent individuals. METHOD: Participants were treatment seeking parolees who were actively using cocaine and had a history of cocaine dependence. Subjects were randomly assigned to a fixed titration of vigabatrin (N=50) or placebo (N=53) in a 9-week double-blind trial and 4-week follow-up assessment. Cocaine use was determined by directly observed urine toxicology testing twice weekly. The primary endpoint was full abstinence for the last 3 weeks of the trial. RESULTS: Full end-of-trial abstinence was achieved in 14 vigabatrin-treated subjects (28.0%) versus four subjects in the placebo arm (7.5%). Twelve subjects in the vigabatrin group and two subjects in the placebo group maintained abstinence through the follow-up period. The retention rate was 62.0% in the vigabatrin arm versus 41.5% in the placebo arm. Among subjects who reported prestudy alcohol use, vigabatrin, relative to placebo, was associated with superior self-reported full end-of-trial abstinence from alcohol (43.5% versus 6.3%). There were no differences between the two groups in drug craving, depressed mood, anxiety, or Clinical Global Impression scores, and no group differences in adverse effects emerged. CONCLUSIONS: This first randomized, double-blind, placebo-controlled trial supports the safety and efficacy of short-term vigabatrin treatment of cocaine dependence. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1278?rss=1">
<title>Randomized, Single-Blind, Controlled Trial of a Specialist Behavior Therapy Team for Challenging Behavior in Adults With Intellectual Disabilities [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1278?rss=1</link>
<description><![CDATA[
OBJECTIVE: Community-based specialist behavior therapy teams may be helpful in managing challenging behavior, but evidence of their effectiveness is limited. This study was designed to examine the effectiveness and costs associated with treatment by a specialist behavior therapy team. METHOD: This was a parallel-group, randomized, single-blind controlled trial carried out in an intellectual disabilities service in England. Participants were 63 male and female service users with mild to severe intellectual disability who presented with challenging behavior. The interventions were standard treatment plus applied behavioral analysis (N=32) and standard treatment only (N=31). The primary outcome measure was challenging behavior, as measured by total and subscale scores on the Aberrant Behavior Checklist 3 and 6 months after randomization. Secondary outcome measures were psychiatric comorbidity assessed at 3 and 6 months using the Psychiatric Assessment Schedule for Adults With a Developmental Disability Checklist (PAS-ADD) and total costs recorded at 6 months. Multilevel modeling was used to compare square root transformations of Aberrant Behavior Checklist scores. RESULTS: Significant differences were found in the transformed total scores on the Aberrant Behavior Checklist (difference=&ndash;0.89, 95% CI=&ndash;1.74 to &ndash;0.04) and transformed lethargy and hyperactivity subscale scores (common intervention effect=&ndash;0.56, 95% CI=&ndash;0.97 to &ndash;0.15). Standard care participants fared worse on the PAS-ADD comorbid organic disorder subscale. There was a clear trend for lower overall costs of the intervention. CONCLUSIONS: Use of a specialist behavior therapy team in addition to standard treatment appears to be more effective in improving challenging behavior and may have financial advantages over standard treatment. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1286?rss=1">
<title>An fMRI Study of the Effects of Psychostimulants on Default-Mode Processing During Stroop Task Performance in Youths With ADHD [Articles]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1286?rss=1</link>
<description><![CDATA[
OBJECTIVE: The authors examined the effect of psychostimulants on brain activity in children and adolescents with ADHD performing the Stroop Color and Word Test. METHOD: The authors acquired 52 functional MRI scans in 16 youths with ADHD who were known responders to stimulant medication and 20 healthy comparison youths. Participants with ADHD were scanned on and off medication in a counterbalanced design, and comparison subjects were scanned once without medication. RESULTS: Stimulant medication significantly improved suppression of default-mode activity in the ventral anterior cingulate cortex in the ADHD group. When off medication, youths with ADHD were unable to suppress default-mode activity to the same degree as comparison subjects, whereas when on medication, they suppressed this activity to comparison group levels. Greater activation of the lateral prefrontal cortex when off medication predicted a greater reduction in ADHD symptoms when on medication. Granger causality analyses demonstrated that activity in the lateral prefrontal and ventral anterior cingulate cortices mutually influenced one another but that the influence of the ventral anterior cingulate cortex on the lateral prefrontal cortex was significantly reduced in youths with ADHD off medication relative to comparison subjects and increased significantly to normal levels when ADHD youths were on medication. CONCLUSIONS: Psychostimulants in youths with ADHD improved suppression of default-mode activity in the ventral anterior cingulate and posterior cingulate cortices, components of a circuit in which activity has been shown to correlate with the degree of mind-wandering during attentional tasks. Stimulants seem to improve symptoms in youths with ADHD by normalizing activity within this circuit and improving its functional interactions with the lateral prefrontal cortex. 
]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1295?rss=1">
<title>Dropouts and Missing Data in Psychiatric Clinical Trials [Letters to the Editor]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1295?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1295-a?rss=1">
<title>Drs. Hamer and Simpson Reply [Letters to the Editor]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1295-a?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1296?rss=1">
<title>Drs. Damaraju, Olson, and Canuso Reply [Letters to the Editor]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1296?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1296-a?rss=1">
<title>Perinatal Akathisia: Implications for Pharmacokinetic Changes During Pregnancy [Letters to the Editor]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1296-a?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1297?rss=1">
<title>Venous Thromboembolism Prophylaxis on Inpatient Psychiatry Units [Letters to the Editor]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1297?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1298?rss=1">
<title>Ziprasidone and Citalopram Use in Pregnancy and Lactation in a Woman With Psychotic Depression [Letters to the Editor]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1298?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1298-a?rss=1">
<title>Patients and Text Messaging: A Boundary Issue [Letters to the Editor]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1298-a?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1299?rss=1">
<title> [Corrections]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1299?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1300?rss=1">
<title>Patient Tales: Case Histories and the Uses of Narrative in Psychiatry [Book Forum]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1300?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1301?rss=1">
<title>Philosophical Issues in Psychiatry [Book Forum]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1301?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1301-a?rss=1">
<title>Understanding Addiction as Self Medication: Finding Hope Behind the Pain [Book Forum]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1301-a?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1302?rss=1">
<title>Before Prozac: The Troubled History of Mood Disorders in Psychiatry [Book Forum]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1302?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ajp.psychiatryonline.org/cgi/content/short/166/11/1304?rss=1">
<title> [Books Received]</title>
<link>http://ajp.psychiatryonline.org/cgi/content/short/166/11/1304?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1154?rss=1">
<title>About This Journal [About This Journal]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1154?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1158?rss=1">
<title>This Month in Archives of General Psychiatry [This Month in Archives of General Psychiatry]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1158?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1159?rss=1">
<title>Cattleya Orchid and Three Brazilian Hummingbirds [Art and Images in Psychiatry]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1159?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1162?rss=1">
<title>Altered Effect of Dopamine Transporter 3&#x27;UTR VNTR Genotype on Prefrontal and Striatal Function in Schizophrenia [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1162?rss=1</link>
<description><![CDATA[
Context&nbsp; The dopamine transporter plays a key role in the regulation of central dopaminergic transmission, which modulates cognitive processing. Disrupted dopamine function and impaired executive processing are robust features of schizophrenia.
Objective&nbsp; To examine the effect of a polymorphism in the dopamine transporter gene (the variable number of tandem repeats in the 3' untranslated region) on brain function during executive processing in healthy volunteers and patients with schizophrenia. We hypothesized that this variation would have a different effect on prefrontal and striatal activation in schizophrenia, reflecting altered dopamine function.
Design&nbsp; Case-control study.
Setting&nbsp; Psychiatric research center.
Participants&nbsp; Eighty-five subjects, comprising 44 healthy volunteers (18 who were 9-repeat carriers and 26 who were 10-repeat homozygotes) and 41 patients with DSM-IV schizophrenia (18 who were 9-repeat carriers and 23 who were 10-repeat homozygotes).
Main Outcome Measures&nbsp; Regional brain activation during word generation relative to repetition in an overt verbal fluency task measured by functional magnetic resonance imaging. Main effects of genotype and diagnosis on activation and their interaction were estimated with analysis of variance in SPM5.
Results&nbsp; Irrespective of diagnosis, the 10-repeat allele was associated with greater activation than the 9-repeat allele in the left anterior insula and right caudate nucleus. Trends for the same effect in the right insula and for greater deactivation in the rostral anterior cingulate cortex were also detected. There were diagnosis&nbsp;x&nbsp;genotype interactions in the left middle frontal gyrus and left nucleus accumbens, where the 9-repeat allele was associated with greater activation than the 10-repeat allele in patients but not controls.
Conclusions&nbsp; Insular, cingulate, and striatal function during an executive task is normally modulated by variation in the dopamine transporter gene. Its effect on activation in the dorsolateral prefrontal cortex and ventral striatum is altered in patients with schizophrenia. This may reflect altered dopamine function in these regions in schizophrenia.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1173?rss=1">
<title>The Catatonia Syndrome: Forgotten but Not Gone [Review]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1173?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1178?rss=1">
<title>Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression: The REVAMP Trial [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1178?rss=1</link>
<description><![CDATA[
Context&nbsp; Previous studies have found that few chronically depressed patients remit with antidepressant medications alone.
Objective&nbsp; To determine the role of adjunctive psychotherapy in the treatment of chronically depressed patients with less than complete response to an initial medication trial.
Design&nbsp; This trial compared 12 weeks of (1) continued pharmacotherapy and augmentation with cognitive behavioral analysis system of psychotherapy (CBASP), (2) continued pharmacotherapy and augmentation with brief supportive psychotherapy (BSP), and (3) continued optimized pharmacotherapy (MEDS) alone. We hypothesized that adding CBASP would produce higher rates of response and remission than adding BSP or continuing MEDS alone.
Setting&nbsp; Eight academic sites.
Participants&nbsp; Chronically depressed patients with a current DSM-IV&ndash;defined major depressive episode and persistent depressive symptoms for more than 2 years.
Interventions&nbsp; Phase 1 consisted of open-label, algorithm-guided treatment for 12 weeks based on a history of antidepressant response. Patients not achieving remission received next-step pharmacotherapy options with or without adjunctive psychotherapy (phase 2). Individuals undergoing psychotherapy were randomized to receive either CBASP or BSP stratified by phase 1 response, ie, as nonresponders (NRs) or partial responders (PRs).
Main Outcome Measures&nbsp; Proportions of remitters, PRs, and NRs and change on Hamilton Scale for Depression (HAM-D) scores.
Results&nbsp; In all, 808 participants entered phase 1, of which 491 were classified as NRs or PRs and entered phase 2 (200 received CBASP and MEDS, 195 received BSP and MEDS, and 96 received MEDS only). Mean HAM-D scores dropped from 25.9 to 17.7 in NRs and from 15.2 to 9.9 in PRs. No statistically significant differences emerged among the 3 treatment groups in the proportions of phase 2 remission (15.0%), partial response (22.5%), and nonresponse (62.5%) or in changes on HAM-D scores.
Conclusions&nbsp; Although 37.5% of the participants experienced partial response or remitted in phase 2, neither form of adjunctive psychotherapy significantly improved outcomes over that of a flexible, individualized pharmacotherapy regimen alone. A longitudinal assessment of later-emerging benefits is ongoing.
Trial Registration&nbsp; clinicaltrials.gov Identifier: NCT00057551
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1189?rss=1">
<title>Altered Corticostriatal Functional Connectivity in Obsessive-compulsive Disorder [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1189?rss=1</link>
<description><![CDATA[
Context&nbsp; Neurobiological models of obsessive-compulsive disorder (OCD) emphasize disturbances in the function and connectivity of brain corticostriatal networks, or "loops." Although neuroimaging studies of patients have supported this network model of OCD, very few have applied measurements that are sensitive to brain connectivity features.
Objective&nbsp; Using resting-state functional magnetic resonance imaging, we tested the hypothesis that OCD is associated with disturbances in the functional connectivity of primarily ventral corticostriatal regions, measured from coherent spontaneous fluctuations in the blood oxygenation level&ndash;dependent (BOLD) signal.
Design&nbsp; Case-control cross-sectional study.
Setting&nbsp; Hospital referral OCD unit and magnetic resonance imaging facility.
Participants&nbsp; A total of 21 patients with OCD (10 men, 11 women) and 21 healthy control subjects matched for age, sex, and estimated intelligence.
Main Outcome Measures&nbsp; Voxelwise statistical parametric maps testing the strength of functional connectivity of 4 striatal seed regions of interest (dorsal caudate nucleus, ventral caudate/nucleus accumbens, dorsal putamen, and ventral putamen) with remaining brain areas.
Results&nbsp; For both groups, there was a clear distinction in the pattern of cortical connectivity of dorsal and ventral striatal regions, consistent with the notion of segregated motor, associative, and limbic corticostriatal networks. Between groups, patients with OCD had significantly increased functional connectivity along a ventral corticostriatal axis, implicating the orbitofrontal cortex and surrounding areas. The specific strength of connectivity between the ventral caudate/nucleus accumbens and the anterior orbitofrontal cortex predicted patients' overall symptom severity (r2&nbsp;=&nbsp;0.57; P&nbsp;&lt;&nbsp;.001). Additionally, patients with OCD showed evidence of reduced functional connectivity of the dorsal striatum and lateral prefrontal cortex, and of the ventral striatum with the region of the midbrain ventral tegmental area.
Conclusions&nbsp; This study directly supports the hypothesis that OCD is associated with functional alterations of brain corticostriatal networks. Specifically, our findings emphasize abnormal and heightened functional connectivity of ventrolimbic corticostriatal regions in patients with OCD.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1201?rss=1">
<title>Interactive Effect of Stressful Life Events and the Serotonin Transporter 5-HTTLPR Genotype on Posttraumatic Stress Disorder Diagnosis in 2 Independent Populations [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1201?rss=1</link>
<description><![CDATA[
Context&nbsp; The 5-HTTLPR polymorphism in the promoter region of the serotonin transporter gene (SLC6A4) has been found to moderate several categories of emotional response after stressful life events. Previous studies generally focused on its effect on depressive symptoms; little is known about its moderation of the development of posttraumatic stress disorder (PTSD).
Objective&nbsp; To examine the effects of childhood adversity, adult traumatic events, 5-HTTLPR genotypes, and gene&nbsp;x&nbsp;environment interactions on the etiology of PTSD.
Design&nbsp; A cross-sectional study in which participants in several studies investigating the genetics of substance dependence were also screened for lifetime PTSD. The triallelic system of 5-HTTLPR was genotyped. Logistic regression modeling was used in the analyses.
Setting&nbsp; General community.
Participants&nbsp; Five hundred eighty-two European American and 670 African American individuals who reported experiences of childhood adversity, adult traumatic events, or both.
Main Outcome Measure&nbsp; Diagnosis of PTSD, defined by DSM-IV diagnostic criteria and assessed through the Semi-Structured Assessment for Drug Dependence and Alcoholism interview.
Results&nbsp; Childhood adversity and adult traumatic events both predicted PTSD. Although the 5-HTTLPR genotype alone did not predict the onset of PTSD, it interacted with adult traumatic events and childhood adversity to increase the risk for PTSD, especially for those with high rates of both types of trauma exposure (European American: odds ratio [OR], 2.86; 95% confidence interval [CI], 1.50-5.45; P&nbsp;=&nbsp;.002; African American: OR, 1.88; 95% CI, 1.04-3.40; P&nbsp;=&nbsp;.04; pooled: OR, 2.31; 95% CI, 1.50-3.56; P&nbsp;&lt;&nbsp;.001).
Conclusions&nbsp; Participants who had both childhood adversity and adult traumatic events were more likely to develop lifetime PTSD compared with those who experienced either type of adverse event. The risk was increased in individuals with 1 or 2 copies of the S&rsquo; (S) allele compared with the L&rsquo; (L) homozygotes. Our study provides additional direct evidence that PTSD is influenced by the interactive effect of environmental and genetic factors.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1214?rss=1">
<title>Posttraumatic Stress Disorder and Health-Related Quality of Life in Patients With Coronary Heart Disease: Findings From the Heart and Soul Study [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1214?rss=1</link>
<description><![CDATA[
Context&nbsp; Posttraumatic stress disorder (PTSD) is increasingly recognized as a cause of substantial disability. In addition to its tremendous mental health burden, PTSD has been associated with worse physical health status and an increased risk of cardiovascular disease.
Objective&nbsp; To determine whether PTSD is associated with cardiovascular health status in patients with heart disease and whether this association is independent of cardiac function.
Design&nbsp; Cross-sectional study.
Setting&nbsp; The Heart and Soul Study, a prospective cohort study of psychological factors and health outcomes in adults with stable cardiovascular disease.
Participants&nbsp; One thousand twenty-two men and women with coronary heart disease.
Main Outcome Measures&nbsp; Posttraumatic stress disorder was assessed using the Computerized Diagnostic Interview Schedule for DSM-IV. Cardiac function was measured using left ventricular ejection fraction, treadmill exercise capacity, and inducible ischemia on stress echocardiography. Disease-specific health status was assessed using the symptom burden, physical limitation, and quality of life subscales of the Seattle Angina Questionnaire. We used ordinal logistic regression to evaluate the association of PTSD with health status, adjusted for objective measures of cardiac function.
Results&nbsp; Of the 1022 participants, 95 (9%) had current PTSD. Participants with current PTSD were more likely to report at least mild symptom burden (57% vs 36%), mild physical limitation (59% vs 44%), and mildly diminished quality of life (62% vs 35%) (all P&nbsp;&le;&nbsp;.001). When adjusted for cardiovascular risk factors and objective measures of cardiac function, PTSD remained independently associated with greater symptom burden (odds ratio, 1.9; 95% confidence interval, 1.2-2.9; P&nbsp;=&nbsp;.004); greater physical limitation (odds ratio, 2.2; 95% confidence interval, 1.4-3.6; P&nbsp;=&nbsp;.001); and worse quality of life (odds ratio, 2.5; 95% confidence interval, 1.6-3.9; P&nbsp;&lt;&nbsp;.001). Results were similar after excluding participants with depression.
Conclusions&nbsp; Among patients with heart disease, PTSD is more strongly associated with patient-reported cardiovascular health status than objective measures of cardiac function. Future studies should explore whether assessing and treating PTSD symptoms can improve function and quality of life in patients with heart disease.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1221?rss=1">
<title>Brain Structural Abnormalities and Mental Health Sequelae in South Vietnamese Ex-Political Detainees Who Survived Traumatic Head Injury and Torture [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1221?rss=1</link>
<description><![CDATA[
Context&nbsp; A pilot study of South Vietnamese ex&ndash;political detainees who had been incarcerated in Vietnamese reeducation camps and resettled in the United States disclosed significant mental health problems associated with torture and traumatic head injury (THI).
Objectives&nbsp; To identify structural brain alterations associated with THI and to investigate whether these deficits are associated with posttraumatic stress disorder and depression.
Design&nbsp; Cross-sectional neuroimaging study.
Setting&nbsp; Massachusetts General Hospital and McLean Hospital.
Participants&nbsp; A subsample of Vietnamese ex&ndash;political detainees (n&nbsp;=&nbsp;42) and comparison subjects (n&nbsp;=&nbsp;16) selected from a community study of 337 ex&ndash;political detainees and 82 comparison subjects.
Main Outcome Measures&nbsp; Scores on the Vietnamese versions of the Hopkins Symptom Checklist&ndash;25 (HSCL) and Harvard Trauma Questionnaire for depression and posttraumatic stress disorder, respectively; cerebral regional cortical thickness; and manual volumetric morphometry of the amygdala, hippocampus, and thalamus.
Results&nbsp; Ex&ndash;political detainees exposed to THI (n&nbsp;=&nbsp;16) showed a higher rate of depression (odds ratio, 10.2; 95% confidence interval, 1.2-90.0) than those without THI exposure (n&nbsp;=&nbsp;26). Ex&ndash;political detainees with THI had thinner prefrontotemporal cortices than those without THI exposure (P&nbsp;&lt;&nbsp;.001 by the statistical difference brain map) in the left dorsolateral prefrontal and bilateral superior temporal cortices, controlling for age, handedness, and number of trauma/torture events (left superior frontal cortex [SFC], P&nbsp;=&nbsp;.006; left middle frontal cortex, P&nbsp;=&nbsp;.01; left superior temporal cortex [STC], P&nbsp;=&nbsp;.007; right STC, P&nbsp;=&nbsp;.01). Trauma/torture events were associated with bilateral amygdala volume loss (left, P&nbsp;=&nbsp;.045; right, P&nbsp;=&nbsp;.003). Cortical thinning associated with THI in the left SFC and bilateral STC was related to HSCL depression scores in THI-exposed (vs non&ndash;THI-exposed) ex&ndash;political detainees (left SFC, P for interaction&nbsp;=&nbsp;.007; left STC, P for interaction&nbsp;=&nbsp;.03; right STC, P for interaction&nbsp;=&nbsp;.02).
Conclusions&nbsp; Structural deficits in prefrontotemporal brain regions are linked to THI exposures. These brain lesions are associated with the symptom severity of depression in Vietnamese ex&ndash;political detainees.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1233?rss=1">
<title>Association of the Glutamate Transporter Gene SLC1A1 With Atypical Antipsychotics-Induced Obsessive-compulsive Symptoms [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1233?rss=1</link>
<description><![CDATA[
Context&nbsp; Several studies have indicated that atypical antipsychotics (AAP) induce obsessive-compulsive (OC) symptoms. Research exploring the mechanism of this phenomenon, however, has been extremely limited. Considering the indirect evidence of genetic control and difficulties in developing animal models and performing gene expression studies, genetic association studies could be an important approach to understanding the molecular mechanism of AAP-induced OC symptoms. The glutamate transporter gene SLC1A1, which was recently reported to be associated with obsessive-compulsive disorder (OCD), is a promising candidate gene for susceptibility to AAP-induced OC symptoms.
Objective&nbsp; To determine whether polymorphisms in SLC1A1 are associated with AAP-induced OC symptoms in patients with schizophrenia.
Design&nbsp; A pharmacogenetic case-control association study.
Setting&nbsp; Outpatient schizophrenia clinics.
Patients&nbsp; Clinically stable patients with schizophrenia who were receiving AAP treatment (n&nbsp;=&nbsp;94; OC group). The OC group consisted of 40 patients with AAP-induced OC symptoms, and the non-OC group consisted of 54 patients who had received AAP for more than 24 months without developing OC symptoms.
Main Outcome Measures&nbsp; Allele, genotype, and haplotype frequencies. The association was tested with a logistic regression model using age, sex, and medication type as covariates.
Results&nbsp; Trends of association were observed in rs2228622 and rs3780412 (nominal P&nbsp;=&nbsp;.01; adjusted permutation P&nbsp;=&nbsp;.07) for the dominant model that was the inheritance model that best fit our data. In the haplotype -based analysis, the A/C/G haplotype at rs2228622-rs3780413-rs3780412 showed a significant association with AAP-induced OC symptoms; this association withstood multiple test correction (nominal P&nbsp;=&nbsp;.01; adjusted permutation P&nbsp;=&nbsp;.04; odds ratio,&nbsp;3.955; 95% confidence interval, 1.366-11.452, for dominant model).
Conclusions&nbsp; These results suggest that sequence variations in SLC1A1 are associated with susceptibility to AAP-induced OC symptoms. This is the first published pharmacogenetic study on this phenomenon and provides preliminary evidence of the involvement of glutamatergic neurotransmission in the pathogenesis of AAP-induced OC symptoms.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1244?rss=1">
<title>Orbitofrontal Cortex and Drug Use During Adolescence: Role of Prenatal Exposure to Maternal Smoking and BDNF Genotype [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1244?rss=1</link>
<description><![CDATA[
Context&nbsp; Prenatal exposure to maternal cigarette smoking (PEMCS) may affect brain development and behavior in adolescent offspring.
Objective&nbsp; To evaluate the involvement of the orbitofrontal cortex (OFC) in mediating the relationship between PEMCS and substance use.
Design&nbsp; Cross-sectional analyses from the Saguenay Youth Study aimed at evaluating the effects of PEMCS on brain development and behavior among adolescents. Nonexposed adolescents were matched with adolescents exposed prenatally to cigarette smoking by maternal educational level.
Participants and Setting&nbsp; A French Canadian founder population of the Saguenay&ndash;Lac-Saint-Jean region of Quebec, Canada.
The behavioral data set included 597 adolescents (275 sibships; 12-18 years of age), half of whom were exposed in utero to maternal cigarette smoking. Analysis of cortical thickness and genotyping were performed using available data from 314 adolescents.
Main Outcome Measures&nbsp; The likelihood of substance use was assessed with the Diagnostic Interview Schedule for Children Predictive Scales. The number of different drugs tried by each adolescent was assessed using another questionnaire. Thickness of the OFC was estimated from T1-weighted magnetic resonance images using FreeSurfer software.
Results&nbsp; Prenatal exposure to maternal cigarette smoking is associated with an increased likelihood of substance use. Among exposed adolescents, the likelihood of drug experimentation correlates with the degree of OFC thinning. In nonexposed adolescents, the thickness of the OFC increases as a function of the number of drugs tried. The latter effect is moderated by a brain-derived neurotrophic factor (BDNF) genotype (Val66Met).
Conclusions&nbsp; We speculate that PEMCS interferes with the development of the OFC and, in turn, increases the likelihood of drug use among adolescents. In contrast, we suggest that, among nonexposed adolescents, drug experimentation influences the OFC thickness via processes akin to experience-induced plasticity.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1253?rss=1">
<title>A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1253?rss=1</link>
<description><![CDATA[
Context&nbsp; Little direct evidence exists on the relative efficacies of different smoking cessation pharmacotherapies, yet such evidence is needed to make informed decisions about their clinical use.
Objective&nbsp; To assess the relative efficacies of 5 smoking cessation pharmacotherapy interventions using placebo-controlled, head-to-head comparisons.
Design&nbsp; A randomized, double-blind, placebo-controlled clinical trial.
Setting&nbsp; Two urban research sites.
Patients&nbsp; One thousand five hundred four adults who smoked at least 10 cigarettes per day during the past 6 months and reported being motivated to quit smoking. Participants were excluded if they reported using any form of tobacco other than cigarettes; current use of bupropion; having a current psychosis or schizophrenia diagnosis; or having medical contraindications for any of the study medications.
Interventions&nbsp; Participants were randomized to 1 of 6 treatment conditions: nicotine lozenge, nicotine patch, sustained-release bupropion, nicotine patch plus nicotine lozenge, bupropion plus nicotine lozenge, or placebo. In addition, all participants received 6 individual counseling sessions.
Main Outcome Measures&nbsp; Biochemically confirmed 7-day point-prevalence abstinence assessed at 1 week after the quit date (postquit), end of treatment (8 weeks postquit), and 6 months postquit. Other outcomes were initial cessation, number of days to lapse, number of days to relapse, and latency to relapse after the first lapse.
Results&nbsp; All pharmacotherapies differed from placebo when examined without protection for multiple comparisons (odds ratios, 1.63-2.34). With such protection, only the nicotine patch plus nicotine lozenge (odds ratio, 2.34, P&nbsp;&lt;&nbsp;.001) produced significantly higher abstinence rates at 6-month postquit than did placebo.
Conclusion&nbsp; While the nicotine lozenge, bupropion, and bupropion plus lozenge produced effects that were comparable with those reported in previous research, the nicotine patch plus lozenge produced the greatest benefit relative to placebo for smoking cessation.
]]></description>
</item>

<item rdf:about="http://archpsyc.ama-assn.org/cgi/content/short/66/11/1263?rss=1">
<title>Vascular Factors and Markers of Inflammation in Offspring With a Parental History of Late-Onset Alzheimer Disease [Original Article]</title>
<link>http://archpsyc.ama-assn.org/cgi/content/short/66/11/1263?rss=1</link>
<description><![CDATA[
Context&nbsp; Alzheimer disease (AD) is a complex disorder with a strong heritable component. Amyloid pathology, vascular factors, and inflammation are postulated to be involved in its pathogenesis, but causality has not been established unequivocally.
Objective&nbsp; To identify heritable traits in middle age that contribute to AD.
Design&nbsp; We used a proven family design, comparing middle-aged offspring with and without a parental history of AD. In such a design, the offspring under study are enriched for risk factors of AD but do not yet have the disease.
Setting&nbsp; The Netherlands.
Participants&nbsp; Two hundred six offspring of 92 families with a parental history of late-onset AD and 200 offspring of 97 families without a parental history of AD.
Main Outcome Measures&nbsp; The APOE 4 genotype, vascular factors, production capacity of pro- and anti-inflammatory cytokines upon stimulation with lipopolysaccharide, and circulating markers of inflammation. All outcome measures were assessed in the offspring only and not in the parental generation.
Results&nbsp; More offspring with a parental history of AD carried APOE 4 than those without a parental history of the disease (47% vs 21%, P&nbsp;&lt;&nbsp;.001). Those with a parental history of AD also had higher systolic blood pressures (P&nbsp;=&nbsp;.006), higher diastolic blood pressures (P&nbsp;&lt;&nbsp;.001), and lower ankle brachial indices (P&nbsp;=&nbsp;.005) when compared with offspring without a family history of dementia. Production capacity of pro-inflammatory cytokines in offspring with a parental history of AD was also different, with higher levels of IL-1&beta; (interleukin 1&beta;) (P&nbsp;&lt;&nbsp;.001), IL-1&beta; to IL-1ra ratio (P&nbsp;&lt;&nbsp;.001), tumor necrosis factor  (P&nbsp;=&nbsp;.008), IL-6 (P&nbsp;=&nbsp;.04), and interferon  (P&nbsp;=&nbsp;.01). All of these positive associations were independent of APOE 4 genotype.
Conclusions&nbsp; Hypertension and the expression of an innate pro-inflammatory cytokine profile in middle age are early risk factors of AD in old age. For the offspring of affected families, it provides clues for screening and preventive strategies, of which blood pressure control can be implemented directly.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/353?rss=1">
<title>Editorial Leadership of Academic Psychiatry [EDITORIALS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/353?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/357?rss=1">
<title>Academic Psychiatry, twenty years ago. . . [EDITORIALS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/357?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/358?rss=1">
<title>Psychopharmacology Curriculum Field Test [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/358?rss=1</link>
<description><![CDATA[
 OBJECTIVE: As part of an effort to improve psychopharmacology training in psychiatric residency programs, a committee of residency training directors and associate directors adapted an introductory schizophrenia presentation from the American Society of Clinical Psychopharmacology&rsquo;s Model Psychopharmacology Curriculum to develop a multimodal, interactive training module. This article describes the module, its development, and the results of a field trial to test its feasibility and usefulness. METHODS: Nineteen residency programs volunteered to use the module during the first half of the 2007&ndash;2008 academic year. Evaluation consisted of a structured phone interview with the training director or teaching faculty of participating programs during February and early March 2008, asking whether and how they used the curriculum, which components they found most useful, and how it was received by faculty and residents. RESULTS: Of the 19 programs, 14 used the module and 13 participated in the evaluation. The most commonly used components were the pre- and postmodule questions, video-enhanced presentation, standard presentation, problem- or team-based teaching module, and other problem-based teaching modules. No two programs used the module in the same fashion, but it was well received by instructors and residents regardless of use. CONCLUSION: The results of this field trial suggest that a dynamic, adult-centered curriculum that is exciting, innovative, and informative enough for a wide variety of programs can be developed; however, the development and programmatic barriers require considerable time and effort to overcome.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/364?rss=1">
<title>The Research Innovation and Scholarship in Education Program: An Innovative Way to Nurture Education [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/364?rss=1</link>
<description><![CDATA[
 OBJECTIVE: Education is becoming a recognized career path in psychiatry. Yet, there are few published accounts of how to create sustainable structures within departments to support this academic focus. The authors document the creation and 5-year progress of the Research Innovation and Scholarship in Education (RISE) program at the largest psychiatry department in Canada. METHODS: The authors analyzed the RISE archive of early proposals for enhancing scholarship in the department, the 5-year plan, annual reports, and curricular vitae of members and also gathered testimonials from inaugural residents and fellows of the program. Materials were analyzed using Boyer&rsquo;s framework of scholarship. RESULTS: Organizationally, RISE has embodied all four tenets of Boyer&rsquo;s model of scholarship. The program has allowed education research, teaching, and creative professional development to flourish in the department, and there are considerably fewer barriers to pursuing an education career path. However, as the program expands, more work needs to be done to increase funding and protected time so that even more residents, fellows, and faculty can engage in educational scholarship. CONCLUSION: Enhancing medical education scholarship through a model that actively integrates research with teaching, creative professional development, and mentorship can help the trajectories of faculty and students wishing to make education a priority in their careers.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/370?rss=1">
<title>Psychiatrists&#x27; Perceptions and Practices in Treating Patients&#x27; Obesity [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/370?rss=1</link>
<description><![CDATA[
 OBJECTIVE: This study identified psychiatrists&rsquo; perceptions and practices regarding advising and treating obese patients. METHODS: Questionnaires were mailed to a national random sample of 500 members of APA. A three-wave mailing was used to maximize the return rate. The questionnaire contained items on weight control based on the Stages of Change and Health Belief models, Self-Efficacy theory, and the 5As strategy. RESULTS: A total of 236 psychiatrists responded to the survey. Most did not have any formal training during medical school on treating obese patients and three-quarters evaluated their training in psychiatric residency programs on weight loss/control issues as "not adequate at all" or "not very adequate." The majority regularly assisted their obese patients with weight management. Most psychiatrists felt confident to ask, advise, assess, assist, and arrange (5As) regarding weight loss issues and believed that doing so would result in significant weight loss. The majority were more likely to advise obese patients to lose weight when comorbid conditions were present. The most common barriers to aiding obese patients were time constraints, poor patient compliance, lack of clear guidelines and practice tools, limited medical training on the issue, and fear of offending patients. CONCLUSION: Patients can no longer afford to have their psychiatrists provide cursory assistance with obesity. Weight management training should be incorporated into psychiatric residency training and continuing education programs.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/376?rss=1">
<title>Ex-Con [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/376?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/377?rss=1">
<title>Mentors&#x27; Perspectives on Group Mentorship: A Descriptive Study of Two Programs in Child and Adolescent Psychiatry [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/377?rss=1</link>
<description><![CDATA[
 OBJECTIVE: The authors assess mentors&rsquo; perceptions of mentoring and experiences participating in an intensive, small-group mentorship program, with particular attention to potential challenges in their retention and the recruitment of new mentors to similar, future programs. METHODS: Similar group mentorship programs were implemented at two child and adolescent psychiatry conferences, one national and the other international. The program included three daily small group meetings, one closing meeting for all participants, and administration of a web-based survey. RESULTS: Of the 43 mentors, 42 (98%) completed the survey, and results were comparable across both programs. Among respondents, 93% found the group experience personally fulfilling and an equally valuable teaching and learning opportunity. Mentors unanimously agreed that co-mentoring enhanced the group mentoring experience. Group diversity enhanced the mentorship process, although differences in trainees&rsquo; interests and levels of experience as posed concrete challenges. Sixty-two percent of the mentors thought that they would be able to adapt lessons and experiences from the mentorship program in their home institutions, and 95% agreed to participate if invited to mentor in future programs. CONCLUSION: Mentors found the intensive, brief group mentorship model to be a powerful, time-efficient, and enjoyable approach to mentoring, increasing trainees&rsquo; exposure to child and adolescent psychiatry. Although group composition, schedule coordination, and logistics warrant closer scrutiny, these positive perceptions bode well for mentor recruitment and retention and for using a similar program in other settings.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/383?rss=1">
<title>Psychiatry Morbidity and Mortality Rounds: Implementation and Impact [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/383?rss=1</link>
<description><![CDATA[
 OBJECTIVE: This study assessed the implementation of psychiatry morbidity and mortality rounds (M&amp;Ms) on the clinical and educational practice in a children&rsquo;s hospital. METHODS: Attendees to monthly M&amp;Ms between July 2005 and May 2007 included staff and trainees from psychiatry, psychology, nursing, and social work. Cases were selected based on a priori risk criteria and each rated on the hospital&rsquo;s four-level risk management scale. M&amp;Ms were reviewed for recurrent patterns that contributed to adverse patient care. Attendees completed a survey at the end of each year, evaluating the educational value of the rounds. RESULTS: Possible opportunities for patient care improvement were found in 80% of the cases and fell into four overlapping areas: diagnostic/formulation errors, communication problems, system-based problems, and class/culture misunderstandings. Identifying these problems led to corrective actions and positive changes in patient care. CONCLUSION: M&amp;Ms appear to be a potentially productive venue for self-appraisal and case review to aid psychiatry programs in patient safety efforts and clinician education.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/389?rss=1">
<title>Adolescent Depression: Evaluating Pediatric Residents&#x27; Knowledge, Confidence, and Interpersonal Skills Using Standardized Patients [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/389?rss=1</link>
<description><![CDATA[
 OBJECTIVE: The authors aim to determine whether pediatric residents used DSM-IV criteria to diagnose major depressive disorder and how this related to residents&rsquo; confidence in diagnosis and treatment skills before and after clinical training with depressed adolescents. METHODS: Pediatric residents evaluated two different standardized patients portraying major depressive disorder before and after learning about adolescent depression. Residents&rsquo; interactions with standardized patients were observed, and checklists containing DSM-IV criteria for major depressive disorder and other pertinent information, such as comorbidities, were completed for each interaction. After the encounter, residents completed a survey asking about the "patient&rsquo;s" diagnosis and the residents&rsquo; confidence in their clinical skills. RESULTS: Residents assessed significantly more checklist items in the second encounter with a standardized patient. Residents&rsquo; confidence in treatment was significantly higher after the rotation, while confidence in diagnostic skills was unchanged, remaining high. Even after the rotation, residents did not use all DSM-IV criteria for major depressive disorder in their diagnoses. CONCLUSION: Major depressive disorder is a common adolescent psychiatric disorder. Pediatricians must be equipped with appropriate interpersonal and diagnostic skills to detect this and other psychiatric disorders. Standardized patients represent one useful way to teach and assess these skills. This study suggests that residents&rsquo; interpersonal and diagnostic skills can improve with practice. Although resident scores improved, post-encounter checklists showed that residents were still not asking all the necessary questions for a DSM-IV diagnosis, concluding prematurely that the standardized patients had major depressive disorder before satisfying all diagnostic criteria. The majority did not consider other depressive conditions or comorbid disorders.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/393?rss=1">
<title>Psychiatrist-In-Training [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/393?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/394?rss=1">
<title>An Innovative Child CBT Training Model for Community Mental Health Practitioners in Ontario [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/394?rss=1</link>
<description><![CDATA[
 OBJECTIVE: Cognitive behavior therapy (CBT) for children has been shown efficacious, but community access to it is often limited by the lack of trained therapists. This study evaluated a child, CBT-focused, 20-session weekly group supervision seminar with a didactic component which was provided to community mental health practitioners by experienced CBT therapists from an academic center. METHODS: Twenty-two practitioners from four community mental health agencies completed the training in four groups (one for each agency); one group was trained by videoconference. The authors assessed outcomes immediately after the training and at 6-month follow-up using a mixed-method design including quantitative and qualitative methods to ensure a comprehensive evaluation. RESULTS: Participants&rsquo; knowledge on a multiple-choice test of child CBT increased with training, as did their self-reported confidence using CBT and desire to do further child CBT. Therapist age and use of an intake diagnostic screen related to positive outcomes, and participants advocated for more structured training. CONCLUSION: Child CBT can be successfully taught to community practitioners using this training model, but refinement based on participant feedback and further studies that include direct observation of CBT skills are needed.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/399?rss=1">
<title>Behind the Scenes [RESEARCH ARTICLES]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/399?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/400?rss=1">
<title>Introducing Evidence-Based Practice to an Inpatient Child and Adolescent Psychiatry Unit [BRIEF REPORTS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/400?rss=1</link>
<description><![CDATA[
 OBJECTIVE: An evidence-based practice (EBP) course was presented to the nonphysician clinical staff of an inpatient child psychiatry unit to assess change in attitude and knowledge. METHODS: Staff members were surveyed to determine change in attitudes and knowledge. RESULTS: The staff gained knowledge about EBP and attitudes were positive overall, indicating that the staff was much more likely to use EBP after the course. CONCLUSION: This study demonstrates the feasibility of teaching EBP to inpatient child psychiatry staff, although the small sample size was a significant limitation and further studies are indicated.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/403?rss=1">
<title>Writing Clearly but With Confusion [BRIEF REPORTS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/403?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/404?rss=1">
<title>Relationship Between Resident-In-Training Examination in Psychiatry and Subsequent Certification Examination Performances [BRIEF REPORTS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/404?rss=1</link>
<description><![CDATA[
 OBJECTIVE: This study analyzed the relationship between performance on The American College of Psychiatrists&rsquo; Psychiatry Resident-In-Training Examination (PRITE) and the ABPN Part 1 examination. METHODS: Pearson correlation coefficients were used to examine the relationship between performance on the 2002 PRITE and the 2003 Part 1 examination for 297 examinees. RESULTS: The correlation between the PRITE global psychiatry and the Part 1 psychiatry scores was 0.59, and the correlation between the PRITE global neurology and the Part 1 neurology scores was 0.39. CONCLUSION: Although the PRITE and the Part 1 examination have different purposes and are developed independently, the significant correlations between scores on the two tests support the use of PRITE results to guide preparation for the Part 1 examination. Guidelines for PRITE scores associated with poor performance on the Part 1 examination are provided.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/407?rss=1">
<title>Journal Club Experience in a Postgraduate Psychiatry Program in Chile [BRIEF REPORTS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/407?rss=1</link>
<description><![CDATA[
 OBJECTIVE: Literature about journal clubs in postgraduate psychiatry programs is scarce, and there is no reference to residents' preferences. METHODS: Residents were asked to respond to a survey about their general satisfaction with the current journal club format and paper preferences, according to subject, scope, and type. RESULTS: Residents' general satisfaction was high. Residents preferred clinically relevant meta-analyses and randomized controlled trials about mood and psychotic disorders, neuroscience, and biological therapies. CONCLUSION: There is a trend to prefer articles related to biological aspects of psychiatry, centered in evidence-based medicine methodology. An effort should be made to broaden the scope of selection of papers, incorporating, for instance, humanistic views, psychotherapy, and other methodologies.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/410?rss=1">
<title>A Residency Training in Rural Psychiatry [BRIEF REPORTS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/410?rss=1</link>
<description><![CDATA[
 OBJECTIVE: This article describes a residency training program that incorporates a rural didactic curriculum and rural clinical training. METHODS: Residents participate in didactic seminars and a rural clinical rotation. RESULTS: In this jointly funded (academic-state-agency) model, faculty members from a community-based medical school train psychiatric residents at a rural clinic. This model differs from a primary care model because it is a direct care model and not a consultation model. CONCLUSION: Locations near medical schools that are within driving distance of a rural or rural/manufacturing community could use this model. It would require modification (including telemedicine) where greater distances are involved or where faculty clinical work must be done at the medical school site to support a university-based hospital or clinic.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/413?rss=1">
<title>Computer Simulation and Virtual Reality in the Diagnosis and Treatment of Psychiatric Disorders [MEDIA COLUMN]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/413?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/417?rss=1">
<title>A Perfect Answer [MEDIA COLUMN]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/417?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/418?rss=1">
<title>Post-Katrina Stabilization of the LSU/Ochsner Psychiatry Residency Program: Caveats for Disaster Preparedness [RESOURCE]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/418?rss=1</link>
<description><![CDATA[
 OBJECTIVE: The Louisiana Health Science Center/Ochsner Hospital psychiatric residency was displaced in August 2005 by Hurricane Katrina to multiple state hospitals and clinics throughout Louisiana. The program encountered many difficulties and learned many lessons about disaster preparedness. METHODS: The LSU/Ochsner Residency Director at the time of Hurricane Katrina chronicles challenges in reestablishing educational program infrastructure in the face of a disaster. RESULTS: Seven caveats of disaster preparedness and program reestablishment are outlined. CONCLUSION: No program can be completely prepared for the unpredictable nature of a sudden disaster, which disrupts an entire residency program years in the making. However, an analysis of the LSU Health Science Center psychiatric residency reveals seven caveats which may help other residency programs in case of a future disaster.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/422?rss=1">
<title>White Coats [RESOURCE]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/422?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/423?rss=1">
<title>A Survey of British Senior Psychiatry Trainees&#x27; Ethnocultural Personal Values [INTERNATIONAL EDUCATION REPORT]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/423?rss=1</link>
<description><![CDATA[
 OBJECTIVE: The authors explored the ethnocultural values of a group of senior psychiatry trainees in the northwest region of England. METHODS: The authors surveyed senior psychiatry trainees using the Personal Values Questionnaire and analyzed responses under the headings of ethnic stereotypes, ethnocultural service issues, and perceptions of racism. They also explored training requirements on cultural issues in a subsample of trainees. RESULTS: The majority of the trainees disagreed with certain commonly held ethnic stereotypes and acknowledged the role of culture in mental health. However, they had contrasting views on the need for culture-specific services and on perceptions of racism. They expressed interest in training programs on cultural issues in psychiatric practice. CONCLUSION: In multicultural settings, personal beliefs, perceptions, and values are likely to influence psychiatric practice. A training program on cultural aspects of mental health could help improve awareness and sensitivity of these issues and the quality of care.
]]></description>
</item>

<item rdf:about="http://ap.psychiatryonline.org/cgi/content/short/33/5/427?rss=1">
<title>Geriatric Triple Board Residency or Post-Geriatrics Portal Project [LETTERS]</title>
<link>http://ap.psychiatryonline.org/cgi/content/short/33/5/427?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&#x26;db=PubMed&#x26;cmd=Retrieve&#x26;list_uids=19819115&#x26;dopt=Abstract">
<title>Weight control programme for schizophrenia: Bridge between psychiatrists and primary care physicians.</title>
<link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&#x26;db=PubMed&#x26;cmd=Retrieve&#x26;list_uids=19819115&#x26;dopt=Abstract</link>
<description><![CDATA[
	
        Weight control programme for schizophrenia: Bridge between psychiatrists and primary care physicians.
        Eur Psychiatry. 2009 Oct 8;
        Authors:  Bankovska Motlova L, Dragomirecka E, Kitzlerova E
        
        PMID: 19819115 [PubMed - as supplied by publisher]
    ]]></description>
</item>

</rdf:RDF>